Intuitive Surgical Declines on Warning Letter From FDA

Intuitive Surgical Inc.’s sales trajectory may have hit a wall amid regulatory scrutiny over adverse events during operations using its surgical robots and concerns on whether the $1.5 million devices are cost effective.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.